American Cancer Society Expert Urges FDA Panel to Oppose Reduced Access to Effective Pain Medications
WASHINGTON, D.C. January 25, 2013 An American Cancer Society expert testified today at a meeting of the Food and Drug Administration (FDA) Drug Safety and Risk Management Advisory Committee on the potential danger to cancer patients of rescheduling certain pain medications.